Jeff Yass’s Maze Therapeutics MAZE Stock Holding History
Bought
Maintained
Sold
Other funds holding MAZE
Jeff Yass's MAZE Position: Q3 2026 in Review
Jeff Yass sold out of Maze Therapeutics (MAZE) in Q3 2026, closing a stake of 23,677 shares — an estimated $657K sold.
Jeff Yass first reported a position in MAZE in Q1 2025 and held it in 5 quarters. The position peaked at $755K in Q1 2026. 158 funds tracked by Wall St. Rank hold MAZE as of Q3 2026.
- Jeff Yass reported no remaining Maze Therapeutics position as of Q3 2026 after selling out during the quarter.
- Jeff Yass sold 23,677 Maze Therapeutics shares in Q3 2026, an estimated $657K.
- Jeff Yass first reported a position in Maze Therapeutics in Q1 2025 and held it in 5 quarters.
- Jeff Yass's Maze Therapeutics position peaked at $755K in Q1 2026.
- 158 funds tracked by Wall St. Rank held Maze Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.